Early stage investors in Cambridge, Massachusetts
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | F-Prime F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics. Cambridge, United States |
Health care, Fintech | Seed, Early stage venture, Late stage venture | 25% | 4 |
| 2 | Founder Collective Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell. Cambridge, United States |
Artificial intelligence, Commerce | Seed, Early stage venture, Late stage venture | 6% | 3 |
| 3 | Matrix Matrix invests in early-stage technology startups, with recent companies including Houmo.AI and Luma AI. Cambridge, United States |
Hardware, Artificial intelligence | Seed, Early stage venture | 32% | 3 |
| 4 | Mission BioCapital Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio. Cambridge, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 20% | 2 |
| 5 | The Engine The Engine supports new companies working on scientific and technological innovation, with recent companies including Hyperlight and Emvolon. Cambridge, United States |
Hardware, Health care | Seed, Early stage venture | 36% | 2 |
Table 1. Early stage investors in Cambridge, Massachusetts: venture capital and micro VC funds ranked by companies whose Series A and B round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Atlas Venture | Venture capital firm | Cambridge, United States | •••@atlasventure.com | 857 20••• |
| Founder Collective | Venture capital firm | Cambridge, United States | •••@foundercollective.com | (617) ••• |
| F-Prime | Venture capital firm | Cambridge, United States | •••@fprimecapital.com | |
| Accomplice | Family office | Cambridge, United States | •••@accomplice.co | 617-58••• |
| SBXi | Venture capital firm | Cambridge, United States | •••@sbxi.com | |
| MIT delta v | Startup accelerator | Cambridge, United States | •••@mit.edu | 617-25••• |
| Sanofi Ventures | Corporate venture arm | Cambridge, United States | •••@gmail.com | +1 617••• |
| E14 Fund | Micro VC fund | Cambridge, United States | •••@e14fund.com | +1 617••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Atlas Venture | B••• B••• | Partner | b•••@atlasventure.com | In the CSV |
| Matrix | D••• S••• | General Partner | d•••@matrix.vc | In the CSV |
| Founder Collective | A••• H••• | General Partner | a•••@foundercollective.com | In the CSV |
| F-Prime | S••• J••• | General Partner and Co-Founder, Investing in AI Native Software | s•••@fprimecapital.com | In the CSV |
| Accomplice | S••• A••• D••• | Operating Partner | s•••@accomplice.co | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 55 of the 115 early stage investors in Cambridge, Massachusetts have a published email address, 46 a phone number and 98 a website.
- Atlas Venture has the most recorded investments, 638, 179 of them as lead investor.
- 20 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Founder Collective is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 691 portfolio companies (76%).
- Seed is the most common investment stage, recorded for 70 of them (61%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Early stage investors in Cambridge, Massachusetts
30 of 115, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Atlas Venture | Venture capital firm | Cambridge, United States | Health care, Biotech | Diagonal Therapeutics | 1 | 638 | 179 | 199 | •••@atlasventure.com | 857 20••• | In the CSV |
| 2 | Matrix | Venture capital firm | Cambridge, United States | Hardware, Artificial intelligence | Houmo.AI, Ampersand, Outset | 4 | 585 | 190 | 151 | (617) ••• | In the CSV | |
| 3 | Founder Collective | Venture capital firm | Cambridge, United States | Artificial intelligence, Commerce | Baselayer, WHOOP, Ownwell | 5 | 543 | 35 | 161 | •••@foundercollective.com | (617) ••• | In the CSV |
| 4 | F-Prime | Venture capital firm | Cambridge, United States | Health care, Fintech | T-Therapeutics, Albert Invent, Immuneel Therapeutics | 4 | 540 | 133 | 113 | •••@fprimecapital.com | In the CSV | |
| 5 | Accomplice | Family office, Venture capital firm | Cambridge, United States | Fintech, Artificial intelligence | Veera | 1 | 386 | 101 | 88 | •••@accomplice.co | 617-58••• | In the CSV |
| 6 | Flagship Pioneering | Venture capital firm | Cambridge, United States | Biotech, Health care | Inari, Prologue Medicines, Quotient Therapeutics | 288 | 104 | 72 | 617-86••• | In the CSV | ||
| 7 | SR One | Venture capital firm | Cambridge, United States | Biotech, Health care | Asceneuron | 214 | 69 | 69 | (610) ••• | In the CSV | ||
| 8 | SBXi | Venture capital firm | Cambridge, United States | Health care, Hardware | SPORO Health, XanderGlasses, Basalt Tech | 196 | 0 | 6 | •••@sbxi.com | In the CSV | ||
| 9 | CVP Management | Micro VC fund, Venture capital firm | Cambridge, United States | Hardware, Commerce | TimeTrade, Podium Data, FamilyID | 152 | 16 | 37 | In the CSV | |||
| 10 | MIT delta v | Startup accelerator, University program | Cambridge, United States | Hardware, Health care | VideaHealth, VSPARTICLE, TracFlo | 129 | 67 | 21 | •••@mit.edu | 617-25••• | In the CSV | |
| 11 | Castle Island Ventures | Venture capital firm | Cambridge, United States | Fintech, Cybersecurity | Meow | 1 | 126 | 42 | 10 | 617-40••• | In the CSV | |
| 12 | Sanofi Ventures | Corporate venture arm | Cambridge, United States | Biotech, Health care | i2o Therapeutics, Tisento Therapeutics, NGI | 119 | 31 | 28 | •••@gmail.com | +1 617••• | In the CSV | |
| 13 | Johnson & Johnson Innovation | Corporate venture arm | Cambridge, United States | Health care, Biotech | ONL Therapeutics, Flindr Therapeutics, Asgard Therapeutics | 118 | 39 | 26 | In the CSV | |||
| 14 | E14 Fund | Micro VC fund | Cambridge, United States | Artificial intelligence, Hardware | Ramona | 1 | 112 | 12 | 11 | •••@e14fund.com | +1 617••• | In the CSV |
| 15 | HealthCare Ventures | Venture capital firm | Cambridge, United States | 109 | 22 | 36 | •••@hcven.com | 617-25••• | In the CSV | |||
| 16 | Flint Capital | Venture capital firm | Cambridge, United States | Artificial intelligence, Hardware | Bluebricks, Antidote Health, Nokod Security | 101 | 36 | 18 | •••@flintcap.com | In the CSV | ||
| 17 | Clarus Ventures | Venture capital firm | Cambridge, United States | Biotech, Health care | ESBATech | 88 | 38 | 34 | 888-75••• | In the CSV | ||
| 18 | Mission BioCapital | Venture capital firm | Cambridge, United States | Biotech, Health care | Circle Pharma, Cloverleaf Bio, Integrated Biosciences | 4 | 85 | 17 | 19 | •••@missionbiocapital.com | +1 617••• | In the CSV |
| 19 | Safar Partners | Private equity firm, Venture capital firm | Cambridge, United States | Biotech, Health care | Gelmedix | 1 | 85 | 17 | 7 | •••@safar.partners | (646) ••• | In the CSV |
| 20 | The Engine | Venture capital firm | Cambridge, United States | Hardware, Health care | Emvolon, Hyperlight, Kytopen | 4 | 81 | 29 | 3 | •••@engine.xyz | In the CSV | |
| 21 | Romulus Capital | Venture capital firm | Cambridge, United States | Health care, Fintech | Albiware, Lora DiCarlo, Placester | 71 | 34 | 15 | •••@romuluscap.com | +1 888••• | In the CSV | |
| 22 | Link Ventures | Venture capital firm | Cambridge, United States | Commerce, Fintech | Enlaye, Blitzy, Dono | 3 | 71 | 27 | 6 | •••@linkventures.com | In the CSV | |
| 23 | Fairhaven Capital Partners | Venture capital firm | Cambridge, United States | Hardware, Cybersecurity | Pwnie Express, Py, ShopWell | 71 | 20 | 24 | •••@fairhavencapital.com | (617) ••• | In the CSV | |
| 24 | HubSpot Ventures | Corporate venture arm | Cambridge, United States | Artificial intelligence, Commerce | Agency AI, Artisan AI, doola | 64 | 12 | 8 | •••@hubspot.com | +1 888••• | In the CSV | |
| 25 | First Star Ventures | Venture capital firm | Cambridge, United States | Artificial intelligence, Biotech | Bot Auto, Blumen Systems, Oort | 58 | 9 | 9 | •••@firststar.vc | (707) ••• | In the CSV | |
| 26 | Vestigo Ventures | Venture capital firm | Cambridge, United States | Fintech, Artificial intelligence | Advocate Technologies | 1 | 55 | 21 | 7 | •••@vestigoventures.com | 617-78••• | In the CSV |
| 27 | Converge | Venture capital firm | Cambridge, United States | Artificial intelligence, Fintech | Zenskar | 1 | 55 | 4 | 8 | (617) ••• | In the CSV | |
| 28 | MRL Ventures Fund | Corporate venture arm, Venture capital firm | Cambridge, United States | Biotech, Health care | InduPro | 1 | 52 | 8 | 14 | In the CSV | ||
| 29 | Koa Labs | Venture capital firm | Cambridge, United States | Artificial intelligence, Health care | OncoveryCare, Hopara, AskFora | 50 | 0 | 6 | •••@koalab.com | +1 603••• | In the CSV | |
| 30 | Rhapsody Venture Partners | Venture capital firm | Cambridge, United States | Hardware, Artificial intelligence | Polaris Electro-Optics | 1 | 46 | 25 | 2 | •••@rhapsodyvp.com | In the CSV |
Table 2. Early stage investors in Cambridge, Massachusetts: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 115.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Founder Collective | Cambridge, United States | 5 | 119 | Baselayer, WHOOP, Ownwell |
| 2 | F-Prime | Cambridge, United States | 4 | 75 | T-Therapeutics, Albert Invent, Immuneel Therapeutics |
| 3 | Matrix | Cambridge, United States | 4 | 109 | Houmo.AI, Ampersand, Outset |
| 4 | The Engine | Cambridge, United States | 4 | 9 | Emvolon, Hyperlight, Kytopen |
| 5 | Mission BioCapital | Cambridge, United States | 4 | 8 | Circle Pharma, Cloverleaf Bio, Integrated Biosciences |
| 6 | Link Ventures | Cambridge, United States | 3 | 14 | Enlaye, Blitzy, Dono |
| 7 | Mass General Brigham Ventures | Cambridge, United States | 2 | 4 | Claris Biotherapeutics, InStride Health |
| 8 | Castle Island Ventures | Cambridge, United States | 1 | 32 | Meow |
| 9 | Azolla Ventures | Cambridge, United States | 1 | 2 | Aikido Technologies |
| 10 | E14 Fund | Cambridge, United States | 1 | 20 | Ramona |
| 11 | Rhapsody Venture Partners | Cambridge, United States | 1 | 3 | Polaris Electro-Optics |
| 12 | MRL Ventures Fund | Cambridge, United States | 1 | 3 | InduPro |
| 13 | Vestigo Ventures | Cambridge, United States | 1 | 16 | Advocate Technologies |
| 14 | Converge | Cambridge, United States | 1 | 10 | Zenskar |
| 15 | Remiges Ventures | Cambridge, United States | 1 | 3 | Kupando |
Table 3. Early stage investors in Cambridge, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime | 51 to 100 | 2022 |
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn, United States | Series A | $22.0M | 2026-10-27 | $24.5M | The Engine | 11 to 50 | 2021 |
| Meow | Meow offers businesses interest-bearing checking accounts, treasury services, invoicing, and bill pay. | Fintech | New York, United States | Series B | $31.6M | 2026-10-15 | $58.6M | Castle Island Ventures | 11 to 50 | 2021 |
| Albert Invent | Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. | Artificial intelligence | Oakland, United States | Series B | $55.0M | 2026-10-13 | $105.0M | F-Prime | 101 to 250 | 2022 |
| Ampersand | Ampersand provides integration infrastructure for enterprise AI agents and software applications. | Artificial intelligence | San Francisco, United States | Series A | $15.0M | 2026-10-06 | $19.7M | Matrix | 11 to 50 | 2022 |
| Baselayer | Baselayer automates risk assessment and fraud detection for financial and government institutions. | Artificial intelligence | New York, United States | Series A | $35.0M | 2026-09-22 | $82.0M | Founder Collective | 51 to 100 | 2024 |
| Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | E14 Fund | 11 to 50 | 2017 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital | 11 to 50 | 2012 |
| Polaris Electro-Optics | Polaris Electro-Optics develops integrated photonics for communications and computation. | Hardware | Broomfield, United States | Series B | $50.0M | 2026-09-15 | $63.2M | Rhapsody Venture Partners | 11 to 50 | 2021 |
| Cloverleaf Bio | Cloverleaf Bio develops an RNA therapeutic platform for oncology. | Biotech | New Haven, United States | Seed | $33.0M | 2026-09-08 | $33.0M | Mission BioCapital | 1 to 10 | 2023 |
Table 4. Early stage investors in Cambridge, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 525 | 76% |
| Health care | 131 | 19% |
| Artificial intelligence | 126 | 18% |
| Hardware | 111 | 16% |
| Fintech | 106 | 15% |
| Biotech | 77 | 11% |
| Commerce | 62 | 9% |
| Cybersecurity | 50 | 7% |
| Education | 26 | 4% |
| Energy | 6 | 1% |
Table 5. Early stage investors in Cambridge, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 115 | 100% |
| Seed investors | 70 | 61% |
| Late stage investors | 49 | 43% |
| Venture investors | 33 | 29% |
| Private equity investors | 12 | 10% |
| Convertible note investors | 11 | 10% |
| Post IPO investors | 9 | 8% |
| Debt investors | 6 | 5% |
Table 6. Early stage investors in Cambridge, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 10 | 11% |
| 2010s | 45 | 52% |
| 2000s | 17 | 20% |
| 1990s | 5 | 6% |
| 1980s | 4 | 5% |
| 1970s | 3 | 3% |
Table 7. Early stage investors in Cambridge, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include early stage investors and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 115 investors.
- 55 rows carry an email address and 46 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 115 rows: 17 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many early stage investors in Cambridge, Massachusetts are on the list?
- 115, in the file dated 16 November 2026. 20 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 55 of the 115 carry an email address in the download and 46 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 115 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 115 rows, 55 firm email addresses and 46 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 37 of the 55 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.